Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference24 articles.
1. Foulon S, Weill A, Maura G, Dalichampt M, Debouverie M, Moreau T (2015) Prévalence de la sclérose en plaques en France en 2012 et mortalité associée en 2013 à partir des données du Sniiram-PMSI. Rev Epidemiol Santé Publique 63:S14–S22
2. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259.
https://doi.org/10.1016/S0140-6736(17)32154-2
3. Palace J, Duddy M, Bregenzer T, Lawton M, Zhu F, Boggild M, Piske B, Robertson NP, Oger J, Tremlett H, Tilling K, Ben-Shlomo Y, Dobson C (2015) Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. Lancet Neurol 14:497–505.
https://doi.org/10.1016/s1474-4422(15)00018-6
4. Zhornitsky S, Greenfield J, Koch MW, Patten SB, Harris C, Wall W, Alikhani K, Burton J, Busche K, Costello F, Davenport JW, Jarvis SE, Lavarato D, Parpal H, Patry DG, Yeung M, Metz LM (2015) Long-term persistence with injectable therapy in relapsing–remitting multiple sclerosis: an 18-year observational cohort study. PLoS One 10:e0123824.
https://doi.org/10.1371/journal.pone.0123824
5. Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y (2009) Impact of multiple sclerosis relapses on progression diminishes with time. Neurology 73:1616–1623.
https://doi.org/10.1212/WNL.0b013e3181c1e44f
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献